Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Core One Labs Inc. C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. The Company, through its wholly owned subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics.


CSE:COOL - Post by User

Bullboard Posts
Comment by Stranius75on Jun 07, 2018 6:35pm
65 Views
Post# 28142433

RE:Positive news that affects LDS

RE:Positive news that affects LDS

CDPH’s Manufactured Cannabis Safety Branch Announces Formal Re-Adoption of Emergency Regulations

Author: California Department of Public Health
Published: Jun 06, 2018
Sacramento, California

The re-adoption of emergency regulations for cannabis manufacturers, issued by the California Department of Public Health (CDPH), has been approved. The effective period for these regulations and those issued by the Bureau of Cannabis Control and California Department of Food & Agriculture has been extended 180 days while the state licensing authorities finalize permanent regulations.

The re-adopted regulations, summary of changes and findings of emergency can be viewed at the links below:

One of the most prominent changes in this re-adoption is removal of restrictions created by the adult use (“A”) and medicinal (“M”) license designations. Businesses will be able to complete one license application and receive one license allowing them to operate in both markets. Beginning June 6, 2018, designation of cannabis and cannabis products as adult-use or medicinal will primarily occur at the time of retail sale, except for higher-THC products permitted only in the medicinal market.


Bullboard Posts